StockData
Cocrystal Pharma, Inc. logo

Cocrystal Pharma, Inc. (COCP) stock

COCPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$0.98−0.00 (-0.24%)

Close on Nov 16, 2026Market cap $18.83MP/E –Yield –

Cocrystal Pharma total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

For fiscal 2012 it was $181.75K, down 30.3% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2012Dec 31, 2012$181.75K-30.3%
FY2011Dec 31, 2011$260.74K-6.0%
FY2010Dec 31, 2010$277.30K–

More Cocrystal Pharma figures

See a number that looks wrong?